Congenital adrenal hyperplasia (21-hydroxylase deficiency) without demonstrable genetic mutations

  • Saroj Nimkarn
  • , Barbara I. Cerame
  • , Ji Qing Wei
  • , Miroslav Dumic
  • , Renata Žunec
  • , Ljerka Brkljacic
  • , Veselin Škrabić
  • , Maria I. New
  • , Robert C. Wilson

Research output: Contribution to journalArticlepeer-review

35 Scopus citations

Abstract

Congenital adrenal hyperplasia (CAH) owing to 21-hydroxylase deficiency (21-OHD) is the most common inherited defect of adrenal steroid biosynthesis. At least 36 mutations in the CYP21 gene, which is mapped to chromosome 6p21.3, have been described. We performed genetic analysis of the CYP21 gene in a patient with classic 21-OHD CAH and her family. The entire exonic coding regions and intronic regions, as well as the -1 kb 5' upstream promoter region, were thoroughly sequenced and analyzed. Despite extensive sequencing, no mutation was found in this 3.7 kb area. The 11β-hydroxylase defect, closely mimicking the clinical and biochemical phenotype of classic 21-OHD, was excluded by directly sequencing 2.6 kb covering the entire coding of the CYP11B1 gene. Herein we describe a phenotypically and hormonally affected patient with classic simple virilizing 21-OHD CAH who lacks a mutation in the entire CYP21 gene and coding region of the CYP11B1 gene.

Original languageEnglish
Pages (from-to)378-381
Number of pages4
JournalJournal of Clinical Endocrinology and Metabolism
Volume84
Issue number1
DOIs
StatePublished - 1999
Externally publishedYes

Fingerprint

Dive into the research topics of 'Congenital adrenal hyperplasia (21-hydroxylase deficiency) without demonstrable genetic mutations'. Together they form a unique fingerprint.

Cite this